From medicine to business and wellness
Effective January 1, 2022, Medicare covers HCPCS Code G1028 (take-home supply of nasal Naloxone; 2-pack of 8mg per 0.1 mL nasal spray) per the Medicare opioid treatment program.
Subscribe to get the latest posts sent to your email.
Effective July 1, 2022, several sections of Fidelis Care authorization grids will be updated. Sections including Essential Plan, Medicaid, Medicare…
As a result of an increasing violation of billing guidelines when it comes to the billing of influenza vaccines, Medicare…
How to perform vision services through virtual health: an ultimate guide to ocular telemedicine Telemedicine improves the healthcare provider-patient relationship especially…